Physician profile
David Bruni
NPI 1922662790
$6,030.83
in general payments reported to CMS, 2019-2025
9 companies · $3,590 in 2025
The $3,590 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $52.53 · 2024: $2,388 · 2025: $3,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,678 · Food and Beverage: $1,800 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,678.21 |
| Food and Beverage | $1,800.09 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $4,123.71 | 2024-2025 | Djo Surgical |
| Stryker Corporation | $946.78 | 2024-2025 | Mako, Insignia, Salvation |
| Arthrex, INC. | $286.36 | 2025 | |
| Medical Device Business Services, INC. | $245.71 | 2024 | |
| Depuy Synthes Sales INC. | $125.00 | 2024 | Expressew, Dynatape, Dynacord |
| Mission Medical Distribution, LLC | $107.85 | 2025 | |
| Orthalign INC | $90.75 | 2024 | Orthalign Plus |
| Mimedx Group, INC. | $33.83 | 2025 | |
| Core Surgical Group | $18.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bruni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.